Foreign Exchange Rate Assumption -- A GBP/USD planning rate of 1.35 for 2026, representing a $0.02 headwind on constant ...
Q4 2025 Earnings Call February 26, 2026 4:30 AM ESTCompany ParticipantsDomenico Iacovelli - Chief Executive OfficerJavier ...
HanesBrands' contribution since December 1, 2025Fourth quarter operating margin of 9.2%, adjusted operating margin1 of ...
Q4 2025 Earnings Call February 27, 2026 4:30 AM ESTCompany ParticipantsJohan Svanstrom - CEO & Executive DirectorRuaridh Hook ...
Rapid developments in decarbonisation policy, feedstock availability, and refinery-scale process innovation have significantly changed the renewable diesel and biodiesel sector over the past few years ...
ARPAM (Average Revenue Per Active Member) -- $364, a 21% year-over-year increase, resulting from higher-frequency memberships ...
The world's most critical challenges are accelerating at a rapid pace. The R&D methods tasked with solving them are not—until ...
The Marcus Corporation (NYSE: MCS) today reported results for the fourth quarter and fiscal year 2025 ended December 31, 2025 ...
ICU Medical, Inc. (NASDAQ:ICUI) Q4 2025 Earnings Call Transcript February 20, 2026 Operator: Good day, and welcome to the ICU ...
Throughout 2025, Leanafy-powered warehouses processed significant daily order volumes across multiple North American facilities. Individual customers processed between 200 and 5,000 orders per day, ...
The service robotics sector is increasingly transitioning from a research-focused stage toward commercialization-led growth. Nightfood Holdings’ acquisition of intellectual property related to its BIM ...
Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness Recommendation based on phase 2/3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results